Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Genenta Science S.P.A. ADR (GNTA)

Genenta Science S.P.A. ADR (GNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 35,803
  • Shares Outstanding, K 19,146
  • Annual Sales, $ 0 K
  • Annual Income, $ -9,640 K
  • EBIT $ 0 M
  • EBITDA $ -11 M
  • 60-Month Beta 0.57
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.47

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3500 +40.00%
on 11/21/25
2.3900 -20.92%
on 11/10/25
-0.4100 (-17.83%)
since 11/07/25
3-Month
1.3500 +40.00%
on 11/21/25
10.0000 -81.10%
on 10/24/25
-1.5500 (-45.06%)
since 09/08/25
52-Week
1.3500 +40.00%
on 11/21/25
10.0000 -81.10%
on 10/24/25
-3.3599 (-64.00%)
since 12/06/24

Most Recent Stories

More News
Genenta Science Reports Reduced Losses and Strengthened Balance Sheet for H1 2025

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Genenta Science...

GNTA : 1.8200 (-2.67%)
Leadership Change at Genenta Science SpA: Dr. Galimi Appointed Acting CMO

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Genenta Science...

GNTA : 1.8200 (-2.67%)
Genenta Science, SpA Announces Participation in the D. Boral Capital Inaugural Global Conference

Milan, Italy and New York, New York--(Newsfile Corp. - May 8, 2025) - Genenta Science, SpA (NASDAQ: GNTA), today announced its participation in the D. Boral Capital Inaugural Global Conference, taking...

GNTA : 1.8200 (-2.67%)
Oncology Breakthroughs: How Cancer Research Is Advancing in 2025

/CNW/ -- USA News Group News Commentary – Now that World Cancer Day (Feb. 4) has come and gone, the world and the market are looking towards what's being...

ONCY : 0.9961 (+0.40%)
GNTA : 1.8200 (-2.67%)
CELC : 105.83 (+0.19%)
NYT : 64.48 (-0.42%)
SLS : 1.8150 (+4.31%)
ONC.TO : 1.42 (+2.16%)
AMGN : 324.21 (-1.72%)
Corium Pharma Solutions Appoints Mark Sirgo as Chief Executive Officer

Corium Pharma Solutions, Inc. (“Corium Pharma Solutions” or “CPSI”), a leading, full-service contract development and manufacturing organization specializing in novel drug delivery technologies,...

AGRX : 1.5100 (unch)
GNTA : 1.8200 (-2.67%)
PG : 139.69 (-2.62%)
NMTR : 0.0722 (-42.97%)
AmCham Italy and Genenta Science Announce the Bowling Green Bull Initiative

Think tank of Italian companies and entrepreneurs listed or to be listed on US capital markets...

GNTA : 1.8200 (-2.67%)
Genenta to Present at Upcoming Scientific Congresses ASGCT, BTM, ASCO and EHA

MILAN, Italy and NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a clinical-stage biotechnology company pioneering the...

GNTA : 1.8200 (-2.67%)
Genenta Appoints Industry Veteran Tim Obara as Head of Business Development

Extensive experience in business development with AstraZeneca and GSK...

GNTA : 1.8200 (-2.67%)
Genenta Files Annual Report on Form 20-F for Fiscal Year 2021

MILAN, Italy and NEW YORK, May 04, 2022 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (NASDAQ: GNTA), a clinical-stage biotechnology company pioneering the...

GNTA : 1.8200 (-2.67%)
Genenta Progresses to Higher Dosing Cohort in Temferon™ Phase 1/2a Clinical Trial in Glioblastoma Multiforme

No dose limiting toxicity observed in previous three dose level cohortsRepresents a 50% higher dose than highest prior levelUpdate of guidance for trial ...

GNTA : 1.8200 (-2.67%)

Business Summary

Genenta Science S.p.A. is a clinical-stage biotechnology company pioneering the development of hematopoietic stem progenitor cell immuno-gene therapy for solid tumors, including the lead product candidate, Temferon(TM). Genenta Science S.p.A. is based in MILAN, Italy.

See More

Key Turning Points

3rd Resistance Point 2.2167
2nd Resistance Point 2.1433
1st Resistance Point 2.0067
Last Price 1.8200
1st Support Level 1.7967
2nd Support Level 1.7233
3rd Support Level 1.5867

See More

52-Week High 10.0000
Fibonacci 61.8% 6.6957
Fibonacci 50% 5.6750
Fibonacci 38.2% 4.6543
Last Price 1.8200
52-Week Low 1.3500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar